CLAVULIN

This brand name is authorized in Nigeria. It is also authorized in Brazil, Canada, Italy, Mexico.

Active ingredients

The drug CLAVULIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Amoxicillin UNII 804826J2HU - AMOXICILLIN
	Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.
	Read more about Amoxicillin
2	Clavulanic acid UNII Q42OMW3AT8 - CLAVULANATE POTASSIUM
	Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.
	Read more about Clavulanic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2848	Tablet	Clavulin 1G Tablets TAB 875 mg; 125 mg	Film-coated tablet. A white to off-white capsule-shaped film-coated tablet, debossed with ‘AC’ on both sides and a score line on one side	10/11/2020
A4-3022	Powder for suspension	Clavulin Powder for Oral Suspension PWD_F_SOL 200 mg/5 mL; 28.5 mg/5 mL	Powder for Oral Suspension. A white to off-white dry powder for reconstitution in water to form an off-white mixed fruit flavoured suspension	28/05/2021
A4-3477	Tablet	Clavulin 625 mg Tablets TAB 500 mg; 125 mg	Film-coated tablet. A white to off-white oval-shaped film-coated tablet, debossed with ‘AC’ and a score line on one side and plain on the other side	28/05/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CR02	Amoxicillin and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510602005131313, 510602006138311, 510602008130318, 510602009110310, 510602010119318, 510602101130411, 510602102137411, 510602104113410, 510602105111411, 510602201151410, 510602203154417, 510612060048003, 510619040060703, 510619040060803, 510619040060903, 510619040061003
CA	Health Products and Food Branch	01916858, 01916874, 01916882, 02238829, 02238830, 02238831
IT	Agenzia del Farmaco	026138139, 026138192, 026138204, 026138216, 026138228
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	065M2006, 066M98, 215M98, 294M90
NG	Registered Drug Product Database	A4-2848, A4-3022, A4-3477